Pictet Asset Management Holding SA »

Blueprint Medicines shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $108M 1.2M 92.51
2024-03-31 $177M 1.9M 94.85

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Blueprint Medicines

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Rock Springs Capital Management
State Street Corporation
William Blair Investment Management
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Lord, Abbett & Co
Pictet Asset Management Holding SA
Alliancebernstein
Holocene Advisors
Invesco

View all funds holding Blueprint Medicines